Form 4: Merck & Co. Director Thomas H. Glocer Reports Transaction in Phantom Stock
SEC Form 4 Filing
Director Thomas H. Glocer reports acquisition of phantom stock units and disposition of common stock.
Summary
- Thomas H. Glocer, a director at Merck & Co., Inc., filed a Form 4 on April 02, 2025.
- The report details a transaction on March 31, 2025, involving phantom stock and common stock.
- Glocer acquired 543.115 units of phantom stock, each convertible to one share of common stock.
- The price of the derivative security (phantom stock) was $89.76.
- Glocer also disposed of 5,100 shares of common stock.
- Following the reported transactions, Glocer beneficially owns 99,578.6409 derivative securities (phantom stock).
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The phantom stock units will be settled in cash upon the director's termination of service, according to a pre-determined distribution schedule.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of transaction involving phantom stock and common stock |
| 04/02/2025 | Date of Form 4 filing |
Keywords
Form 4, Merck & Co., MRK, Thomas H. Glocer, Phantom Stock, Director, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.